Literature DB >> 3919944

Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.

D Kessel, C Wilberding.   

Abstract

Daunorubicin transport was compared in P388 murine leukemia and in P388/Adramycin (ADR), an anthracycline-resistant subline. We can demonstrate an energy-dependent outward transport system in P388/ADR which limits drug accumulation. Although no calcium requirement for the outward transport process could be shown, several calcium antagonists inhibited outward transport of daunorubicin in P388/ADR and modified the drug resistance pattern. But these agents failed to alter calcium fluxes in either cell line, suggesting that their mode of action in these studies was not related to interactions with calcium-dependent processes. Accumulation differences could not account for the level of daunorubicin resistance observed in the P388/ADR cell line, nor could resistance be wholly circumvented by calcium antagonists.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919944

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

Review 1.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil.

Authors:  A R Safa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

Review 3.  Cellular drug efflux and reversal therapy of cancer.

Authors:  P W Wigler
Journal:  J Bioenerg Biomembr       Date:  1996-06       Impact factor: 2.945

4.  Reversal of multidrug resistance by new dihydropyridines with lower calcium antagonistic activity.

Authors:  T Yoshinari; Y Iwasawa; K Miura; I S Takahashi; T Fukuroda; K Suzuki; A Okura
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 5.  Genetics of multidrug resistance.

Authors:  J M Croop; P Gros; D E Housman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

6.  Endogenous active efflux of norfloxacin in susceptible Escherichia coli.

Authors:  S P Cohen; D C Hooper; J S Wolfson; K S Souza; L M McMurry; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

7.  Pharmacological and molecular characterization of intrinsic and acquired doxorubicin resistance in murine tumor cell lines.

Authors:  B Schott; D Londos-Gagliardi; C Ries; S Huet; J Robert
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells.

Authors:  E Friche; T Skovsgaard; N I Nissen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

9.  Correction of altered plasma membrane potentials. A possible mechanism of cyclosporin A and verapamil reversal of pleiotropic drug resistance in neoplasia.

Authors:  B Vayuvegula; L Slater; J Meador; S Gupta
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 10.  Pharmacologic circumvention of multidrug resistance.

Authors:  J M Ford; W N Hait
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.